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The importance of the physical interaction between 
epidermal Langerhans cells and malignant cells in my-
cosis fungo ides (MF) has been stressed recently. To fur-
ther evaluate this concept, electron microscopic study 
was carried out to identify whether or not Langerhans 
cells are also present in the dermal infiltrates ofMF. The 
cells with characteristic Langerhans cell-granules were 
found in the dermal infiltrates, from early patch to tumor 
lesions of MF. No vacuolous change suggestive of cell 
degeneration was found in these cells. These Langer hans 
cells revealed only a small number of specific granules, 
and nuclear cleavage and chromatin pattern similar to 
those of malignant lymphoid cells, thus hardly differen-
tiating 2 cell types in a low power view. Similar to 
epidermal MF lesions, however, a close apposition of 
dermal Langerhans cells with malignant lymphoid cells 
was seen. In one o-ccasion, one Langerhans cell was 
present at the . epidermodermal junction, appearing as 
being in the process of crossing over the basal lamina. 
Inasmuch as malignant cells in MF have been shown to 
possess the functional properties of helper T cells and 
receptors for Ia (immune associated antigen), expressed 
in the epidermis solely on Langerhans cells, our findings 
may further suggest that these malignant T cells bind to 
Langerhans cells through a "lock and key" mechanism 
involving membrane-bound Ia. 
The origin and function of the Langerhans cells have been 
extensively studied recently. They appear to be derived from 
bone marrow precursors which migrate to the epidermis and 
localize in the suprabasal portion [1]. The epidermal Langer-
hans cells are the target cells involved in such an immune 
reaction as contact allergic hypersensitivity [2]. These cells 
selectively take up the exogenous antigens causing allergic 
contact dermatitis and present the antigens to T cells [3,4]. 
They differ from ordinal monocytes and macrophages in that 
there is the presence of distinctivfi! cytoplasmic organelles, 
Langerhans-cell granules, and by being only moderately phag-
ocytic [5]. 
Study of the mechanism underlying the interaction between 
malignant cells of cutaneous T cell lymphoma (CTCL) and 
Langerhans cells may provide a clue not only to understanding 
the pathogenesis of CTCL, but also to the elucidation of se-
lected aspects on the basic biology of Langerhans cells. Malig-
nant cells in mycosis fungoides (MF) and Sezary's syndrome 
(SS) possess the functional properties of helper T cells [6] and 
receptors for Ia (immune-response associated) antigen, ex-
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pressed in the epidermis solely on Langerhans cells [7,8]. It 
may be possible to hypothesize that these malignant T cells 
bind to Langerhans cells through a "lock and key" mechanism 
involving membrane-bound Ia. If this is the case, one would 
expect to find Langerhans cells in the dermal infiltrates of 
CTCL. 
Although considerable attention has been paid to the ultra-
structural characteristics of epidermal Langerhans cells and 
malignant cells in CTCL, little or none of the literature has 
identified at the ultrastructural level whether or not the Lan-
gerhans cells are present in the dermal infiltrates of CTCL. 
Previously, we have shown that Langerhans cells are present in 
the lymph node~ of dermatopathic lymphadenopathy [9] and 
that the malignant cells in MF and SS possess the surface 
immune property crossreacting to that of peripheral T cells in 
lymph nodes [10]. This study reports on the presence of Lan-
gerhans cells in the dermal infiltrates of MF and compares the 
ultrastructural characteristics of these cells to those of epider-
mal Langerhans cells. 
MATERIALS AND METHODS 
Electron !"llicroscopic study was carried out on skin biopsies taken 
from 8 patients suffering from MF in various stages of involvement; 1 
patient from stage I of MF, 4 from stage II, and 3 from stage III. Prior 
to biopsy, none of the patients had received any specific therapy of 
systemic and/or topical application, e.g., chemo-immunotherapy, nitro-
gen mustard, and PUV A. Diagnosis of MF was made by histopatholog-
ical, immunofluorescent, and electron microscopic criteria reported 
previously [10). The specimens for electron microscopic study were cut 
into small pieces, fixed with 2% pa.raformaldehyde-2% glutaraldehyde 
solution buffered with 0.1 M cacodylate, pH 7.4, postfixed with 2% 
osmium tetroxide in 0.1 M cacodylate buffer, dehydrated by ethanol 
solutions, mounted in epoxy resins, ultrasectioned by a Porter Blum 
microtome and stained with uranyl acetate and lead cib·ate. The 
sections were observed with a Hitachi HS8 electron microscope. 
RESULTS 
Langerhans cells with characteristic rod-and/or racket-
shaped granules were present in both epidermal and dermal 
lesions of MF. As similarly observed previously [11], the Lan-
gerhans cells in the epidermal lesions of MF were scattered 
throughout the entire epidermis, but particularly in the mide-
pidermis. They were always present in Pautrier's microab-
scesses (Fig 1-a) and also often revealed a direct apposition 
with lymphoid cells in spongiotic epidermis. 
The number ofLangerha.ns-cell granules within an epidermal 
Langerhans cell appeared to be parallel to the development of 
other cytoplasmic organelles, e.g., Golgi apparatus and endo-
plasmic reticulum. Those Langerhans cells with a poorly-de-
veloped organelle revealed only a small number of Langer hans-
cell granules (Fig 1-b, c) whereas those cells with a well-devel-
oped organelle exhibited numerous granules (Fig 1-d). When 
the former cells had numerous granules, they often possessed 
dense tubules where amorphous electron dense materials were 
aggregated. These Langerhans cells also contained lysosomal 
granules in which amorphous dense materials, probably de-
graded cell-debris, were occasionally present. The Langerhans 
cells commonly seen in the microabscesses were those cells with 
a small number of Langerhans-cell granules and a poorly dif-
ferentiated organelle. They lacked lysosomal granules and 
phagocytic vacuoles (Fig 1-a, b) . In addition, differentiation of 
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FIG 1. Ultrastructure of the Langerhans cells (LGC ) in an epidermal lesion of mycosis fungoides (MF). a, A low-power view of a Pautrier's 
microabscess. Atypical lymphoid cells ru·e aggregated within the microabscess. It is difficult to di ffe rentiate a Langerhans cell (LGC) at this power 
of the micrograph from surrounding atypical malignant lymphocytes (LC), because both cell types reveal a similar nuclear contour and chromatin 
pattern. BL, Basal lamina and KC, keratinocyte (X 6,000). b, A serial section of the Langerhans cell (LGC) shown in the microabscess of Fig. 1-
a. Only 2 Langerhans-cell granules ru·e seen, both of which ar e encircled (A and B). The insert (the encircled area labeled as A X 63,000) reveals 
a high power view of Langerhans-cell granules (arrow). The cytoplasmic organelles are poorly-developed in t he cell. N, Nucleus and TF, 
tonofilament (X 19,000). c, A high power view of the encircled area of the Langer hans cell shown in Fig 1-b (the encircled area labeled as B) . One 
rod-shaped, Langerhans-cell granule (LG) is seen. (X 25,000). d, Another type of the Langerhans cells (LGC) seen in an Pautrier's microabscess 
in which 2 Langerhans cells are contained. These ceLls reveal dense bodies (DB) , numerous Langerhans-cell granu les (arrow) and well -developed 
organelles. The insert (X 74,000) demonstrated typical examples of the characteristic racket- and rod-shaped granules, and lysosomal dense· body 
(DB) seen in the Langer hans cell of an epidermal lesion of MF. LC, Lymphocyte and LG, Langerhans-cell granule (X 29,000). 
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these Langerhans cells from neighboring atypical lymphoid 
cells was often difficult, inasmuch as both cell types revealed 
similar nuclear chromatin and cleavage (Fig 1-a). 
On one occasion, one Langerhans cell was seen at the epider-
modermal junction of a MF lesion (Fig 2-a, b). In this situation, 
the basal lamina was disrupted by a portion of the cytoplasm 
and dendrite of the Langerhans cell (Fig 2-a). The proximal 
part of the dendrite and cytoplasm located in the dermis was 
characteristically aggregated with numerous microfilaments, 
which took a distribution pattern similar to that seen during a 
cellular locomotion [12] (Fig 2-c). This cell appeared to be in 
the process of crossing over the basal lamina into the dermis 
inasmuch as such an aggregation of microfi.laments was seen 
only in those parts of the cytoplasm and dendrite locating in 
the dermis. The number ofLangerhans cell granules within this 
cell was relatively small, and there were no phagocytic vacuoles. 
Langerhans cells were also present in the dermal infiltrates 
of all stages of MF involvement, from early patch to tumor 
stages. No apparent ultrastructural difference existed in the 
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Langerhans cells among the stages of MF involvement (Fig 3, 
4). Characteristically, the Langerhans cells in the dermal infil-
trates revealed a high cleavage of the nucleus, an aggregation 
of heterochromain along the nuclear envelope and, rarely, a 
nucleolus, similar to those seen in atypical malignant lympho-
cytes (Fig 3-a, c). In addition, these Langerhans cells usually 
revealed only a small number of specific granules, thus hardly 
differentiating themselves from malignant lymphocytes in a low 
power view (Figs 3-b, c, 4-c, d). The rod-shaped granules 
revealed a characteristic regular striation in the center. The 
differentiation of the rod-shaped granules from cross-sectional 
profiles of smooth endoplasmic reticulum was easily made by 
the presence of central striation and occasional anastomosis of 
rod- and racket-shaped bodies. In contrast to epidermal Lan-
gerhans cells, they did not show any lysosomal granules and 
dense tubules nor did they reveal any vacuolous change sugges-
tive of cellular degeneration. Similar to epidermal Langerhans 
cells, however, the development of other organelles such as 
Golgi apparatus and endoplasmic reticulum was poor. A close 
FIG 2. A Langerhans cell which appears to be in the process of migration from the epidermis into the dermis of a mycosis fungoides (MF) 
lesion. a, A tip of the dendrite of a Langerhans cell (LGC) with specific granules (small arrows) disrupting the basal lamina (BL) (large arrows). 
DP, dendritic process; KC, Keratinocyte; N, Nucleus (X 17,000) . b, A high-power view of the Langerhans cell shown in Fig. 2-a (the encircled area 
labeled as A). A fairly large number of Langerhans-cell granu les (w-rows) , either rod-, racket-shaped and/or both, are seen (X 48,000). c, A high-
power view of the tip of the dendrite of the Langerhans cell shown in Fig 2-a (the encircled area labeled as B). The tip of the dendrite (w-rows) 
appears to be in the process of migration into the dermis through the disrupted basal lamina ( BL) inasmu ch as it is aggregated with numerous 
microftlaments (MF) (X 53,900). 
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FIG 3. A Langerhans cell present in the dermal infil trate of mycosis fungoides (plaque stage). a, Two types of cells are seen. Both cell reveal 
s imilar nuclear cleavages, a nd nucleolar ( Nn) and chromatin patterns. One is a Langerhans cell (LGC) a nd other is a n atypical lymphocyte ( LC). 
Only 2 Langerhans-cell granules (the encircled area) , which may be, however, hardly recognizable by the low magnification, are seen in the 
Langerhans cell. CT , Collagen t issue (X 6,000) . b, A high-power view of the highly cleaved nucleus (N) and Langerhans-cell granule shown in Fig. 
3-a (the encircled area labeled as A). A racket-shaped granule is present (arrow) as indicated by the insert (X 32,000). c, A high-power view of 
t he encircled area labeled as B that is shown in Fig 3-a. The development of cytoplasmic organelles is poor a nd one La ngerhans-cell granule (see 
the insert X 51,000) are noted. (X 31,000) . 
apposition of Langerhans cells with malignant lymphoid cells 
was also seen. In the tumor stages of MF, the Langerhans cells 
were seen in the deep dermis in the center of the cell infiltrates 
(Fig 4-a, b, c, d). In an early patch lesion, apposition of Lan-
gerhans cells to atypical malignant lymphocytes was not seen 
as frequently as seen in plaque lesions because of the sparseness 
of cell infiltrates. Occasionally, the Langerhans cells in the 
dermal infiltrates showed lipid droplets (Fig 4-b) . 
DISCUSSION 
Om present study clearly showed that the Langerhans cells, 
whose ultrastructme, except for the presence of a few specific 
granules, closely resembles that of malignant lymphoid cells, 
are present in the dermal infiltrates of MF, and that these cells 
appear to be able to cross over the epidermodermal junction. 
Although the Langerhans cells constitute a fa irly fixed popu-
lation in the epidermis and pilosebaceous system [13,14], they 
appear to be absent in the dermis under normal unstimulated 
conditions. Of the la1·ge number of sections examined in the 
normal human skin, Breathnach could not find one single 
Langerhans cell in the dermis nor could he observe any type of 
the cell in the process of crossing the junction [15]. 
Two major explanations have been offered in terms ofT cell 
specific microenvironment in the skin of CT CL [16,17]; These 
are (a) that CTCL may result from the expansions of malignant 
clones originally derived from normal T cells reactive against 
epidermal antigens or extrinsic antigens that have become 
localized in skin and (b) that neoplastic T cells may "home" in 
skin for reasons completely independent of antigen presenta-
tion. In the context of these explanations, the importance of the 
physiological interaction between Langerhans cells and malig-
nant T cells has been stressed [18]. First, MF and SS possess 
historical and clinical features suggestive of a disease of antigen 
persistence, to which epidermal Langerhans cells may be the 
receptors. A high incidence of habitual exposure to either heavy 
metals known to cause allergic contact hypersensitivity or po-
tentially carcinogenic agents has been reported in the history 
of patients suffering from MF and SS [19]. A significant eleva-
tion of serum IgE and a presence of "auto-antibody" were 
detected in patients of MF and SS, suggesting that CTCL is 
closely related to a chronic response to persistent unidentified 
antigen(s) (20]. Second, malignant cells in CTCL frequently 
exhibit functional properties of polyclonal helper T cells [6], 
upon which Ia positive Langerhans cells may present exogenous 
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FIG 4. A Langerhans cell in dermal infiltrates of mycosis fungoides (tumor stage). a, A low-power view of a Langerhans cell (LGC ) present in 
the center of atypical malignant lymphoid cells (LC) in the dermal infiltrates (x 14,000) . b, A high-power view of racket-shaped granules (arrows) 
are present in the Langerhans cell shown in Fig 4-a (the encircled area labeled as A (X 26,000). c, A high-power view of the cytoplasm of the 
Langerhans cell shown ·in Fig 4-a (the encircled area labeled as B). The development of cytoplasmic organelles are fair ly good and a number of 
Langerhans-cell granules (arrows) are visible. Lipid droplets (LD) with a scalloped border are also present. N, Nucleus (X 16,000). d, A high-
power view of the rod-shaped, Langerhans-cell granules (arrows) shown in Fig 4-c (X 57,000). 
antigens in a way similar to that of contact allergic hypersen-
sitivity. In addition, immunofluorescence study indicated that 
the number of dendritic cells expressing Ia antigen in the 
involved epidermis of MF increased with the severity of the 
disease [21]. Electron microscopic study showed that the focus 
of damage in the epidermis seen in both contact allergy and in 
MF is similar and suggested that it results from the interaction 
between specific T cells and Langerhans cells [11]. Third, and 
most importantly, coexistence of malignant T cells with Ia 
positive dendritic cells has been suggested in CTCL. Edelson 
Feb. 1982 
and his group recently succeeded in developing a m onoclonal 
antibody which r eacts wit h epidermal L a ngerha ns cells a nd 
distinguish es t h ese cells from classical m onocytes by immuno-
histo ch e mistr y [22]. Interestingly, t h ey sh owed t hat cells reac-
tive wit h t his a n tibody a re also scattered a mong t h e m aligna n t 
T cells in t h e dermal infiltra tes of CT CL [23]. 
All of these previous s tudies indicate t h a t m aligna nt h elper 
T cells m ay coexist with La ngerha ns cells not only in th e 
e pidermis but a lso in the dermis of CT CL , a nd our presen t 
s tudy clearly has proved that L a ngerha ns cells ar e indeed 
presen t in the d ermal infiltrates of MF. If one could further 
id e n t ify the m ech a nism of t h e T cell-Lan gerhans cell interac-
tion, one would h ave uncovered som ething very impor tan t 
a bout t h e basic biology of skin . 
The authors express many thanks to Dr. R. L. Edelson for his 
valuable comments in preparing this manuscript, and to Miss T . Nii-
kawa fo r her typing of the manuscript and preparation of the micro-
graphs. 
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